© 2021 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2021 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
January 10, 2020
The study follows others that have found that SB4 works well for the majority of patients who switched from the originator etanercept, Enbrel.
January 09, 2020
Two studies recently reported on Hulio, the adalimumab biosimilar marketed and developed by Mylan and its partner Fujifilm Kyowa Kirin Biologics.